TITLE

Dexamethasone / human chorionic gonadotrophin (hCG) and dexamethasone / nafarelin as a valid diagnostic tests in reproductive aged women with polycystic ovarian syndrome (PCOS)

AUTHOR(S)
Hajder, E.; Hajder, M.
PUB. DATE
March 2010
SOURCE
HealthMed;Mar2010, Vol. 4 Issue 1, p87
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction. Hyperandrogenism is a functional, diagnostic and therapeutic problem of women in reproductive age. The aim of this study was to determine the validity of dexamethasone-human chorion gonadotrophin (DEXA/hCG) and dexamethasone- nafarelin (DEXA/N) testing in the differential hyperandrogenism diagnosis in differentiating polycystiyc ovary syndrome (PCOS) from other forms of hyperandrogenism. Subjects and methods. Prospective study included 30 women of reproductive age with PCOS, selected by diagnostic Rotterdam criteria (group A) and 12 women of reproductive age who are not PCOS (group B). Subgroup A1 (n = 15) and B1 (n = 6) were treated with DEXA/hCG test, subgroups A2 (n = 15) and B2 (n = 6) were treated with DEXA/N test. All respondents had the same parameters: cortisol, dehydroepiandrosterone sulphate (DHEAS), total testosterone, SHBG, free androgen index (FAI) and 17-hydroxyprogesterone (17- OHP) basal, during and after testing. Results: The suppression with dexamethasone during (DEXA /hCG) test in subgroups A1 and B1, the fourth day was followed by a significant decline in average values (p<0.05) DHEAS, testosterone, SHBG, free androgen index (FAI) and 17-OHP in relation to the basal value. After the 5000 IU hCG subgroup A1 was followed by a significant increase 17-OHP (p<0.001), greater than 7 nmol / l, while in subgroup B1 there was significant increase in value (p<0.01) less than 5 nmol/l in relation to the value before giving hCG . In DEXA / N after the suppression test in subgroups A2 and B2 there was a significant decline in average values of (p< 0.05) DHEAS, testosterone, SHBG, FAI and 17-OHP on the fourth day of the test when compared to the basal value. After the injection of nafarelin ampoules of 100 ug in subgroup A2 there was a significant increase in the value of 17-OHP (p<0.001), greater than 7 nmol/l, while the significant increase in subgroup B2 (p<0.01) was 5 nmol /l in relation to the value before injection of nafarelin. Average value of 17- OHP in the DEXA / N test was significantly higher (p<0.001) when compared to the average value of 17-OHP in the DEXA /hCG test in subjects with PCOS. Conclusion: The results of this study showed that DEXA /hCG and DEXA/N are valid tests for the diagnosis of PCOS, but the nafarelin test is more significant.
ACCESSION #
48462340

 

Related Articles

  • Testosterone and the breast. Shufelt, Chrisandra L.; Braunstein, Glenn D. // Menopause International;Jun2008, Vol. 14 Issue 3, p117 

    Although women have been treated with testosterone (T) for female sexual dysfunction since the 1950s, the role of T in normal female physiology is not yet fully defined. One of the major safety concerns of androgen therapy is whether androgens have a stimulatory effect on the breast that could...

  • Androgeny u kobiet pomenopauzalnych. Tkaczuk-Włach, Joanna; Sobstyl, Małgorzata; Jakiel, Grzegorz // Menopausal Review / Przeglad Menopauzalny;2013, Vol. 12 Issue 2, p180 

    An appropriate level of androgens plays an important role in many physiological functions in women, such as sexual, metabolic and psychological ones. It is well established that extreme levels of circulating androgens, whether low or high, may lead to negative effects on women's health. This...

  • Polycystic Ovarian Syndrome. Hudson, Tori // Townsend Letter;Oct2008, Issue 303, p138 

    The article offers information on the polycystic ovarian syndrome (PCOS). According to the article, PCOS is not categorized as a disease because it is not a specific and constant set of symptoms and physical characteristics. It is stated that there are two aspects of PCOS which are the...

  • SET protein up-regulated testosterone production in the cultured preantral follicles. Boqun Xu; Lingling Gao; Yugui Cui; Li Gao; Xue Dai; Mei Li; Yuan Zhang; Xiang Ma; Feiyang Diao; Jiayin Liu // Reproductive Biology & Endocrinology;2013, Vol. 11 Issue 1, p1 

    Background: We found previously that the expression of SET gene was up-regulated in polycystic ovaries. Evidences suggested that SET protein was essential for regulating both the promoter activity of CYP17A1 and the biological activity of P450c17. In this study, we explored whether SET regulated...

  • Androgens and Women at the Menopause and Beyond. Morley, John E.; Perry III, H. Mitchell // Journals of Gerontology Series A: Biological Sciences & Medical ;May2003, Vol. 58 Issue 5, p409 

    Editorial. Focuses on the effect of low-dose testosterone treatment on the libido and psychological well-being of menopausal women with androgen deficiency. Major androgens in women; Difficulties faced by menopausal women; Factors affecting the libido of menopausal women.

  • Validity of Serum Testosterone, Free Androgen Index, and Calculated Free Testosterone in Women with Suspected Hyperandrogenism. Al Kindi, Manal K.; Al Essry, Faiza S.; Al Essry, Fatma S.; Mula-Abed, Waad-Allah S. // Oman Medical Journal;Nov2012, Vol. 27 Issue 6, p471 

    Objectives: There are technical limitations for the currently available methods of measuring serum total and free testosterone in females. The study objectives were to evaluate the usefulness of serum total testosterone, sex hormone-binding globulin (SHBG), free androgen index (FAI), and...

  • Androgen therapy in women: for whom and when. Pluchino, Nicola; Carmignani, Arianna; Cubeddu, Alessandra; Santoro, Anna; Cela, Vito; Alcalà, Tania // Archives of Gynecology & Obstetrics;Oct2013, Vol. 288 Issue 4, p731 

    Androgens play a primary role in female physiopathology. The age-related reduction in the production of ovarian and adrenal androgens may significantly affect women's health. The decline of circulating androgens results from a combination of two events: reduced ovarian production and...

  • testosterone DO YOU NEED IT TOO? Sathicq, Larraine // Good Medicine (Australian Consolidated Press);Sep2004, p53 

    Provides information on the use of testosterone replacement therapy in women. Symptoms of low testosterone; Methods for administering testosterone in the body; Advantages of the therapy to women.

  • Adrenocortical Production Is Associated with Higher Levels of Luteinizing Hormone in Nonobese Women with Polycystic Ovary Syndrome. Luciana; Tock; Gláucia; Carneiro; Andrea Z.; Pereira; Sérgio; Tufik; Maria Teresa; Zanella // International Journal of Endocrinology;2014, p1 

    Objective. Insulin resistance (IR) and ovarian and adrenal hyperandrogenism are a common finding in women with polycystic ovary syndrome (PCOS). The aim of the present study was to access possible differences in insulin resistance, gonadotropins, and androgens production in obese and nonobese...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics